Durably improving health is really, really hard. I’ve discussed this in the context of drug discovery, which must contend with the every-more-apparent reality that biology is incredibly complex, and science remarkably fragile. I’ve discussed this in the context of patient behavior, focusing on the need...
Posted to
News
by
Health. Care.
on
Thu, Apr 5 2012
Filed under:
Filed under: Uncategorized, health, Health care, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Atul Gawande, Peter Pronovost, Patient, Hospital, Patient Protection and Affordable Care Act, New England Journal of Medicine, TechCrunch, Building the Organization of Tomorrow
I’ve just returned from participating in an engaging and highly interactive translational research innovation symposium at this past Thursday put together by Dr. David Epstein at the Duke Eye Center and Chancellor Victor Dzau, and featuring both University faculty and invited external speakers. Four...
Posted to
News
by
Health. Care.
on
Sat, Jan 21 2012
Filed under:
Filed under: health, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Peter Pronovost, Leadership, desmond-hellmann, MIT, entrepreneur, Mark Zuckerberg, Duke University, nancy andrews, Victor Dzau, Judah Folkman, Robert Langer, Tom Byers, ticker=NYSE:SNY
A high-level perspective on select key challenges and opportunities in the healthcare space. I had the opportunity today to speak at the Open Science Summit at the Computer History Museum in Mountain View, CA; the meeting featured a [...] Read More...
Posted to
News
by
Health. Care.
on
Sun, Oct 23 2011
Filed under:
Filed under: health, Medicine, Health care, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Peter Pronovost, Physician, Patient, metrics, Data Driven, measurement, Melinda Gates, value, Computer History Museum
A distinguishing feature of the U.S. healthcare system – let us suspend judgment, for the moment, on whether this is an asset or a liability — would seem to be its variability, the fact that two patients with a similar disease can receive very different care. This may have its historical routes...
Posted to
News
by
Health. Care.
on
Tue, Jun 21 2011
Filed under:
Filed under: health, Medicine, Health care, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Atul Gawande, Strategies & Solutions, Peter Pronovost, evidence-based medicine, Physician, Organizations, Patient